Out of the shadows: Mental health in the Asia Pacific region.
An ageing population, increased life expectancy and the launch of new products are all driving future growth of the CNS market.
Covering a wide range of conditions affecting the nervous system, major diseases include Alzheimer’s disease, multiple sclerosis, Parkinson’s disease, diabetic neuropathy, major depressive disorder (MDD), bipolar disorder, schizophrenia, insomnia, epilepsy, attention deficit hyperactivity disorder (ADHD) and migraine.
The markets for Alzheimer’s disease and multiple sclerosis are expected to witness particular growth due to expected launch of promising molecules with disease- modifying characteristics and novel mechanisms of action.
We can help you with:
Opportunity and demand assessment
Understanding the global and local market opportunity
The patient journey and unmet needs
Segmenting the market
Product and portfolio development
Brand positioning, launch and beyond
Good intentions, bad habits: Reforming mental healthcare in Latin America and the Caribbean.